Rhumbline Advisers lifted its stake in Globe Life Inc. (NYSE:GL – Free Report) by 1.6% in the 2nd quarter, HoldingsChannel reports. The firm owned 212,310 shares of the company’s stock after acquiring an additional 3,292 shares during the period. Rhumbline Advisers’ holdings in Globe Life were worth $26,388,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also bought and sold shares of the stock. Nuveen LLC purchased a new stake in Globe Life in the first quarter worth about $131,608,000. Leith Wheeler Investment Counsel Ltd. grew its stake in shares of Globe Life by 615.9% during the 2nd quarter. Leith Wheeler Investment Counsel Ltd. now owns 656,807 shares of the company’s stock valued at $81,635,000 after acquiring an additional 565,061 shares during the period. Swedbank AB increased its holdings in Globe Life by 77.0% in the 1st quarter. Swedbank AB now owns 832,000 shares of the company’s stock worth $109,591,000 after acquiring an additional 362,000 shares in the last quarter. Jacobs Levy Equity Management Inc. increased its holdings in Globe Life by 35.9% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 1,025,984 shares of the company’s stock worth $135,143,000 after acquiring an additional 271,253 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt raised its stake in Globe Life by 1,270.8% during the 2nd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 233,030 shares of the company’s stock worth $28,963,000 after acquiring an additional 216,030 shares during the period. Institutional investors own 81.61% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on the stock. Truist Financial increased their price objective on shares of Globe Life from $150.00 to $158.00 and gave the stock a “buy” rating in a research note on Friday, October 24th. Wells Fargo & Company lowered their price objective on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research report on Friday, October 24th. Morgan Stanley dropped their price objective on Globe Life from $179.00 to $177.00 and set an “overweight” rating for the company in a research note on Monday, November 17th. Weiss Ratings downgraded Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday. Finally, BMO Capital Markets restated a “market perform” rating and issued a $149.00 price target (up from $114.00) on shares of Globe Life in a research note on Wednesday, July 30th. Seven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $155.56.
Globe Life Price Performance
NYSE:GL opened at $134.97 on Thursday. The business’s 50-day moving average is $136.05 and its 200 day moving average is $131.42. Globe Life Inc. has a 12 month low of $100.27 and a 12 month high of $147.83. The company has a market capitalization of $10.74 billion, a P/E ratio of 9.78 and a beta of 0.55. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.43.
Globe Life (NYSE:GL – Get Free Report) last released its quarterly earnings data on Wednesday, October 22nd. The company reported $4.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.54 by $0.27. The business had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.52 billion. Globe Life had a return on equity of 22.12% and a net margin of 19.36%.During the same quarter in the previous year, the company posted $3.44 EPS. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. On average, equities research analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.
Globe Life Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Monday, January 5th will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Monday, January 5th. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. Globe Life’s dividend payout ratio is presently 7.83%.
Globe Life Profile
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Featured Stories
- Five stocks we like better than Globe Life
- Following Congress Stock Trades
- Why Gold Loves Trump as Much as Trump Loves Gold
- How to Use the MarketBeat Dividend Calculator
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- What does consumer price index measure?
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
